DNMT3A and acute myeloid leukemia: Among these, mutation of DNMT3A has been identified in ~25% acute myeloid leukemia (AML) patients12–15, which gives rise to aberrant DNA methylation patterns and increased cell proliferation16–18, and correlates with poor clinical outcome13.